In the phase 3 PANOVA-3 trial, adding Tumor Treating Fields therapy to gemcitabine and nab-paclitaxel was associated with improved overall survival and delayed pain progression in adults with locally advanced pancreatic cancer.
A national survey shows most US emergency medicine residents plan long-term community-based practice, with lifestyle, burnout, and educational debt shaping career decisions.